Hadassah

Hadassah Survey Highlights Need to Enlighten Israeli Women about Heart Risks

Thursday, Sep 17 2015

“This survey tells us how much work is ahead to educate and inform Israeli women from all sectors,” says Pollin Center Director Dr. Donna Zfat-Zwas.

“Only 34.4 percent of Israeli women know that heart disease is a major cause of death in women,” reports the Hadassah Medical Organization’s Linda Joy Pollin Women's Cardiovascular Wellness Center in sharing the results of its telephone survey of over 1,000 participants.

This finding is despite the fact that heart disease is the number one killer of women throughout the world and in Israel. The Center reveals that in 2011 there were 5,457 deaths from heart disease among women in Israel, as compared to 5,088 deaths from all types of cancers put together.

The survey also found that only 25.9 percent of Arab women recognized heart disease as a major cause of death, even though the rate of heart disease among Arab women in Israel is 57% higher than that of Jewish women.

Although a majority of the women who were interviewed were able to identify some of the symptoms of a heart attack, such as chest pain or chest pressure, most missed other significant risk factors. Only 37.7 percent, for example, named being overweight as a risk factor and only 25.9 percent identified smoking. Less than 20 percent of the women identified cholesterol, family history or lack of physical activity; only 17.6 percent cited hypertension; and only 8.5 percent mentioned diabetes.

“This survey tells us how much work is ahead to educate and inform Israeli women from all sectors,” says Pollin Center Director Dr. Donna Zfat-Zwas. Having just returned from Boston with a master’s degree in public health from Harvard University, Dr. Zfat-Zwas looks forward to applying her new skills in health communication and behavioral change to her work at the Pollin Center on behalf of Israeli women.

 

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Hadassah Removes Tumor;
Gazan Boy Walks for First Time

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More